METSIM (METabolic Syndrome In Men) Study

Request Access

Anthropometry (8)

bmi - Body mass index (phv00265289.v3.p1)
BMI - Body Mass Index (phv00565302.v1.p1)
height - Height (phv00265287.v2.p1)
hip - Hip circumference (phv00265290.v2.p1)
hip - Hip circumference (phv00565304.v1.p1)
waist - Waist circumference (phv00265291.v2.p1)
waist - Waist circumference (phv00565303.v1.p1)
weight - Weight (phv00265288.v2.p1)

Biomarkers (25)

B_GHbA1C - Whole Blood GHbA1c (phv00565307.v1.p1)
chol - Total cholesterol (phv00265283.v2.p1)
cpep_fast - Serum C-peptide (phv00265276.v2.p1)
dbp - Diastolic blood pressure (phv00435312.v2.p1)
DBP - Diastolic blood pressure (phv00565319.v1.p1)
glu_2h - OGTT 120 min plasma glucose (phv00265277.v2.p1)
glu_fast - OGTT fasting plasma glucose (phv00265274.v2.p1)
hba1c - Blood GHbA1C (phv00265279.v3.p1)
hdl - HDL cholesterol (phv00265285.v2.p1)
ins_2h - OGTT 120 min plasma insulin (phv00435310.v1.p1)
ins_fast - OGTT fasting plasma insulin (phv00435309.v1.p1)
ldl - LDL cholesterol (phv00265284.v2.p1)
P_gl0 - Fasting plasma glucose from OGTT (Oral Glucose Tolerance Test) (phv00565308.v1.p1)
P_gl120 - 120 min plasma glucose from OGTT (Oral Glucose Tolerance Test) (phv00565309.v1.p1)
P_ins0 - Fasting plasma insulin from OGTT (Oral Glucose Tolerance Test) (phv00565310.v1.p1)
S_alat - Alanine aminotransferase (phv00565316.v1.p1)
S_hdlc - HDL cholesterol (phv00565315.v1.p1)
s_krea - Creatinine (phv00265281.v2.p1)
S_krea - Creatinine (phv00565317.v1.p1)
S_ldlc - LDL cholesterol (phv00565313.v1.p1)
S_totalc - Total cholesterol (phv00565314.v1.p1)
S_tottg - Total triglycerides (phv00565312.v1.p1)
sbp - Systolic blood pressure (phv00435311.v2.p1)
SBP - Systolic blood pressure (phv00565318.v1.p1)
tg - Total triglycerides (phv00265286.v2.p1)

Demographics (6)

Age - Age at examination date (phv00565301.v1.p1)
aoo - Age of onset of diabetes (phv00265273.v2.p1)
sex - Sex (phv00265270.v2.p1)
SEX - Sex (phv00543159.v1.p1)
SEX - Biological sex (phv00480719.v2.p1)
studyage - Age at METSIM baseline visit (phv00435306.v2.p1)

Medications (3)

bpmeds - Use of blood pressure medication (phv00265295.v2.p1)
diabmeds - Use of diabetes medication (phv00265294.v2.p1)
lipidmeds - Use of lipid medication (phv00265296.v2.p1)

Other (28)

Biopsy_Number - Biopsy number (phv00565298.v1.p1)
cohort - T2D-GENES cohort name (phv00265298.v2.p1)
CONSENT - Consent group (phv00251851.v3.p1)
consortium - Consortium name (phv00265297.v2.p1)
Difference_Biopsy_and_Visit - Time difference between examination and biopsy (phv00565300.v1.p1)
dmtype - Type of diabetes (phv00435307.v1.p1)
FAMILY_ID - Family ID (phv00480715.v2.p1)
FATHER - Father's Subject ID (phv00480717.v2.p1)
fatmass - Fat mass from Bioimpedance (phv00565306.v1.p1)
gltol6_1 - Glucose tolerance according to WHO 1997 (phv00435308.v1.p1)
matsuda - Matsuda index (ISIcomp) (phv00565311.v1.p1)
MOTHER - Mother's Subject ID (phv00480718.v2.p1)
p_adipon - Plasma adiponectin (phv00265282.v2.p1)
s_gadab - Serum GAD antibodies (phv00265280.v2.p1)
SAMPLE_ID - Sample ID (phv00251859.v4.p1)
SOURCE_SUBJECT_ID - Source subject ID (phv00409060.v2.p1)
SOURCE_SUBJECT_ID2 - Source subject ID (phv00543161.v1.p1)
STUDY - Study accession (phv00251860.v4.p1)
SUBJECT_ID - Subject ID (phv00265269.v2.p1)
SUBJECT_ID - Subject ID (phv00565297.v1.p1)
SUBJECT_ID - Deidentified subject ID (phv00251850.v3.p1)
SUBJECT_ID - Subject ID (phv00480716.v2.p1)
SUBJECT_ID - Subject ID (phv00251858.v4.p1)
SUBJECT_SOURCE - Subject source (phv00409059.v2.p1)
SUBJECT_SOURCE2 - Subject source (phv00543160.v1.p1)
Time_between_Biopsies - Time since previous biopsy (phv00565299.v1.p1)
TWIN_ID - Twin ID for monozygotic twins and multiples. An MZ_TWIN_ID is not provided for dizygotic twins or multiples. (phv00480720.v2.p1)
WHR - Waist/hip ratio (phv00565305.v1.p1)